Drug Trial Radar · NCT00947297
Study of the Safety of HPN (Hyperion)-100 for the Long-Term Treatment of Urea Cycle Disorders (Treat UCD)
Last checked: Nov 20, 2026Latest source record: Jul 10, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
60
Actual
Start
Nov 2009
Primary completion
Sep 2011
Study completion Nov 2011
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- Jul 28, 2009
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 6 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This was a long-term safety study HPN-100 in urea cycle disorder (UCD) subjects. Subjects were assessed regularly for safety and control of their venous ammonia. Hyperammonemic events were characterized with respect to contributing factors, such as intercurrent illness, diet, and noncompliance with medication.
Conditions
- Urea Cycle Disorders
Interventions
HPN-100Drug
HPN-100 is a triglyceride that has a similar mechanism of action as NaPBA. It is a liquid with minimal taste and odor. Three teaspoons of HPN-100 (\~17.4 mL) delivers equivalent of PBA that 40 tablets of NaPBA do.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of Adverse Events (Number of Participants Who Experienced Any AE Considered Related to Study Drug)Time frame: 1 year
Locations
22 sites in 2 countries. Site status is shown where the registry gives one.
Long Beach Memorial
Long Beach, California
UCLA
Los Angeles, California
Stanford University
Stanford, California
Children's Hospital Colorado
Aurora, Colorado
Yale School of Medicine
New Haven, Connecticut
Children's National Medical Center
Washington D.C., District of Columbia
University of Florida
Gainesville, Florida
Univeristy of Iowa
Iowa City, Iowa
Maine Medical Center
Portland, Maine
SNBL-Clinical Pharmacology Center
Baltimore, Maryland
Tufts-New England Medical Center
Boston, Massachusetts
University of Minnesota Medical Center
Minneapolis, Minnesota
Mount Sinai School of Medicine
New York, New York
Westchester Medical Center
Valhalla, New York
University Hospitals Case Medical Center
Cleveland, Ohio
Nationwide Children's Hospital
Columbus, Ohio
Oregon Health & Science University
Portland, Oregon
University of Pittsburgh
Pittsburgh, Pennsylvania
Baylor College of Medicine
Houston, Texas
University of Utah
Salt Lake City, Utah
Medical College of Wisconsin
Milwaukee, Wisconsin
The Hospital for Sick Children
Toronto, Ontario, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.